Latest / Chip Stock Investor Podcast
Intuitive Surgical (ISRG) Stock Down 40%: Buy the Dip?
Intuitive Surgical posted double-digit growth in revenue, procedures, and installed base but ISRG stock is down over 40% from its highs. We dig into why the market is repricing this healthcare stock despite strong fundamentals.
Da Vinci procedure growth came in at 15% year-over-year, the installed base grew 12% to nearly 12,000 systems worldwide, and revenue hit $2.9 billion, up 19% year-over-year. Non-GAAP gross margin expanded to 70%. Yet none of that has stopped the stock's slide.
We break down Intuitive Surgical's revenue mix between recurring instruments and accessories, systems revenue…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.